Donafenib vs. lenvatinib combined with transarterial chemoembolization as initial therapy for unresectable hepatocellular carcinoma: a retrospective real-world study

ABSTRACT:

SUBMITTER: Yan H 

PROVIDER: S-EPMC12332680 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature